angiotensin ii has been researched along with fenoldopam in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apparsundaram, S; Chen, CJ; Lokhandwala, MF | 1 |
| Clark, KL; Drew, GM; Hilditch, A; Robertson, MJ | 1 |
| Edwards, RM | 1 |
| Dupont, AG; Lefebvre, RA; Vanderniepen, P | 1 |
| Goldberg, LI; Murphy, MB; Nelson, K; Weber, RR | 1 |
| Karnezis, TA; Murphy, MB; Nelson, KS; Tripathi, BJ; Tripathi, RC; Weber, RR | 1 |
| Chen, C; Lokhandwala, MF | 1 |
| Arendshorst, WJ; Chatziantoniou, C; Ruan, X | 2 |
| Hennes, HJ; Jantzen, JP | 1 |
| Asico, LD; Jose, PA; Li, XX; Xu, J; Yao, LP; Yu, PY | 1 |
| Carey, RM; Felder, RA; Gildea, JJ; Howell, NL; Keller, SR; Kemp, BA; McGrath, HE; Salomone, LJ | 1 |
| Felder, RA; Gildea, JJ; Jose, PA; Wang, X | 1 |
1 trial(s) available for angiotensin ii and fenoldopam
| Article | Year |
|---|---|
Effects of selective dopamine-1 receptor activation on intraocular pressure in man.
Topics: Adolescent; Adult; Angiotensin II; Benzazepines; Blood Pressure; Double-Blind Method; Fenoldopam; Humans; Intraocular Pressure; Male; Norepinephrine; Pupil; Receptors, Dopamine; Receptors, Dopamine D1 | 1988 |
12 other study(ies) available for angiotensin ii and fenoldopam
| Article | Year |
|---|---|
Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Benzazepines; Captopril; Dopamine Agents; Fenoldopam; Kidney; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Renin-Angiotensin System; Sodium | 1991 |
Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Captopril; Diuresis; Dogs; Dopamine Agents; Female; Fenoldopam; Kidney; Male; Peptidyl-Dipeptidase A; Receptors, Dopamine; Vasodilation | 1991 |
Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Benzazepines; Dopamine; Fenoldopam; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Rabbits; Renal Circulation; Vasodilator Agents | 1986 |
Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
Topics: Angiotensin II; Animals; Antipsychotic Agents; Benzazepines; Blood Pressure; Domperidone; Electric Stimulation; Ergolines; Female; Fenoldopam; Male; Norepinephrine; Phenylephrine; Quinpirole; Rats; Rats, Inbred Strains; Splanchnic Circulation; Vasodilator Agents | 1987 |
The role of alpha-adrenoceptor blockade in the antihypertensive effects of fenoldopam in humans.
Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Benzazepines; Blood Pressure; Dose-Response Relationship, Drug; Fenoldopam; Heart Rate; Humans; Male; Norepinephrine | 1988 |
Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Diuresis; Dopamine Agonists; Drug Synergism; Enalaprilat; Fenoldopam; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Cholera Toxin; Cyclic AMP; Fenoldopam; GTP-Binding Proteins; Hematocrit; Hypertension; Kidney; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Signal Transduction; Sodium Fluoride; Species Specificity; Time Factors; Vascular Resistance; Vasoconstriction | 1995 |
Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Angiotensin II; Animals; Bucladesine; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Electromagnetic Phenomena; Fenoldopam; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Rheology; Vasoconstriction; Vasodilator Agents | 1993 |
Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia, General; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Central Venous Pressure; Cerebrovascular Circulation; Dopamine Agents; Dose-Response Relationship, Drug; Female; Fenoldopam; Heart Rate; Hemodynamics; Hypercapnia; Hypertension; Intracranial Pressure; Intraocular Pressure; Male; Ocular Hypertension; Pseudotumor Cerebri; Pulmonary Wedge Pressure; Swine; Vascular Resistance | 1994 |
Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Biological Transport; Fenoldopam; Hypertension; Isoenzymes; Kidney Tubules; Norepinephrine; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine D1; Sodium-Potassium-Exchanging ATPase | 1998 |
Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism.
Topics: Anesthesia; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Benzazepines; Diuresis; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Fenoldopam; Imidazoles; Kidney; Natriuresis; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Dopamine D1; Sodium, Dietary | 2007 |
Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor.
Topics: Angiotensin II; Cell Membrane; Cells, Cultured; CSK Tyrosine-Protein Kinase; Dopamine Agonists; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Extracellular Signal-Regulated MAP Kinases; Fenoldopam; Humans; Kidney Tubules, Proximal; Phosphorylation; Proteasome Endopeptidase Complex; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, Dopamine D1; Receptors, Dopamine D5; src-Family Kinases | 2008 |